Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca A Seale

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Epidemiology|September 30, 2015
TREAT: tamper-resistant envelope allocation technique for a multisite studyJeanelle Sheeder, Rebecca A Seale, Kim D Weber Yorga
Multiple Sclerosis and Related Disorders|July 31, 2020
Validation of the functional assessment of chronic illness therapy - General treatment satisfaction (FACIT-TS-G) in multiple sclerosisEric Engebretson, Rebecca A Seale, Brooke Valdez, et al.
Frontiers in Neurology|October 19, 2020
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer AcetateJustin M Honce, Kavita V Nair, Brian D Hoyt, et al.
Multiple Sclerosis and Related Disorders|August 7, 2021
Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controlsEnrique Alvarez, Kavita V Nair, Brian D Hoyt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Epidemiology|September 30, 2015
TREAT: tamper-resistant envelope allocation technique for a multisite studyJeanelle Sheeder, Rebecca A Seale, Kim D Weber Yorga
Multiple Sclerosis and Related Disorders|July 31, 2020
Validation of the functional assessment of chronic illness therapy - General treatment satisfaction (FACIT-TS-G) in multiple sclerosisEric Engebretson, Rebecca A Seale, Brooke Valdez, et al.
Frontiers in Neurology|October 19, 2020
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer AcetateJustin M Honce, Kavita V Nair, Brian D Hoyt, et al.
Multiple Sclerosis and Related Disorders|August 7, 2021
Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controlsEnrique Alvarez, Kavita V Nair, Brian D Hoyt, et al.
Pageof 1